Clinical Study
Biological Amnion Prevents Flexor Tendon Adhesion in Zone II: A Controlled, Multicentre Clinical Trial
Table 1
Summary of relevant demographic and clinical data.
| Groups | ā | Control | PDLLA | Amnion | Difference | n=21 | n=35 | n=33 | p-value |
| Mean age, years | ā | 42.2 | 40.9 | 43.2 | 0.675 | Gender | Male | 12 | 20 | 23 | 0.500 | Female | 9 | 15 | 10 | Hand, n | Right | 12 | 25 | 19 | 0.408 | Left | 9 | 10 | 14 | Finger, n | 2nd | 11 | 15 | 18 | 0.991 | 3rd | 13 | 23 | 21 | 4th | 9 | 18 | 18 | 5th | 4 | 6 | 4 | Flexor tendon | Superficial and deep | 26 | 47 | 49 | 0.743 | Deep | 10 | 15 | 13 | Pulley, n | Unimpaired | 35 | 49 | 43 | 0.619 | Impaired | 7 | 13 | 7 |
|
|
n=number of patients; PDLLA: poly-DL-lactic acid.
|